,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,6.77386113598822e-06,0.00556811385378232
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,2.3055074126388e-05,0.00947563546594546
3,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.000472784378103275,0.129542919600297
4,WP_IRON_METABOLISM_DISORDERS,10,Up,0.000913816589221156,0.187789309084948
5,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0015687387888699,0.252679074204206
6,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.00184437280441026,0.252679074204206
7,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Up,0.00218368548811399,0.256427067318528
8,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00510106725367549,0.524134660315156
9,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0057571126541249,0.525816289076741
10,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00672821215066719,0.542581024435499
11,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.00762228501551599,0.542581024435499
12,WP_ONECARBON_METABOLISM,22,Up,0.00792089086767151,0.542581024435499
13,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.00937229805721315,0.56843669149527
14,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.00975358471247427,0.56843669149527
15,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Up,0.0106434901590795,0.56843669149527
16,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.0110644611483264,0.56843669149527
17,WP_PROTEASOME_DEGRADATION,57,Up,0.0119839216818735,0.570079801282167
18,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0133884563558477,0.570079801282167
19,WP_IDO_METABOLIC_PATHWAY,7,Down,0.0137327926579719,0.570079801282167
20,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0144973424193906,0.570079801282167
21,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0145640825145079,0.570079801282167
22,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.0162626819716978,0.60763293548798
23,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.020327586397034,0.650195330666116
24,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.0206349053370017,0.650195330666116
25,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.021245557833087,0.650195330666116
26,WP_MONOAMINE_GPCRS,3,Down,0.0218621863334448,0.650195330666116
27,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0230211022266155,0.650195330666116
28,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.0234221795856917,0.650195330666116
29,WP_MALE_INFERTILITY,66,Up,0.023797666302599,0.650195330666116
30,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0261202270589292,0.650195330666116
31,WP_NRF2_PATHWAY,67,Up,0.0264424671024813,0.650195330666116
32,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0266070197712825,0.650195330666116
33,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.026607765619256,0.650195330666116
34,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.0273601513089221,0.650195330666116
35,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.0276847160259295,0.650195330666116
36,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0301839960754896,0.6570981997879
37,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Up,0.0311891296087591,0.6570981997879
38,WP_FERROPTOSIS,50,Up,0.0312949114748726,0.6570981997879
39,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.0319667350044071,0.6570981997879
40,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0327332293280448,0.6570981997879
41,WP_MEVALONATE_PATHWAY,7,Down,0.0327749710356495,0.6570981997879
42,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0346369293317113,0.664378815354401
43,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0350825121383531,0.664378815354401
44,WP_CREATINE_PATHWAY,2,Down,0.0355628562963426,0.664378815354401
45,WP_ZINC_HOMEOSTASIS,21,Up,0.0371276887281817,0.678199114101453
46,WP_BENZOAPYRENE_METABOLISM,5,Up,0.039731783147342,0.709989690154676
47,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Up,0.0433473199778231,0.758116957910012
48,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0467982741815829,0.778808642916807
49,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.0468463883766299,0.778808642916807
50,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.0490017441378692,0.778808642916807
51,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0511287202088048,0.778808642916807
52,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0515284986338993,0.778808642916807
53,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.0523367936121122,0.778808642916807
54,WP_KLEEFSTRA_SYNDROME,24,Down,0.053156135396029,0.778808642916807
55,WP_CAMKK2_PATHWAY,29,Up,0.0539390904882353,0.778808642916807
56,WP_PPARALPHA_PATHWAY,15,Up,0.0541005030233004,0.778808642916807
57,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Down,0.0544225807765387,0.778808642916807
58,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.0549524346583635,0.778808642916807
59,WP_ID_SIGNALING,12,Up,0.0610526432761562,0.846216896504639
60,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.0656988528076555,0.846216896504639
61,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.065945522112389,0.846216896504639
62,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Up,0.0678915867775797,0.846216896504639
63,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.0679823025086742,0.846216896504639
64,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0680180174459966,0.846216896504639
65,WP_DOPAMINE_METABOLISM,7,Up,0.0708586583530958,0.846216896504639
66,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.0714569891575301,0.846216896504639
67,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.0720662618221823,0.846216896504639
68,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Up,0.0721767330247898,0.846216896504639
69,WP_TP53_NETWORK,16,Up,0.0724362224419732,0.846216896504639
70,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.0725253648623644,0.846216896504639
71,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.0730917270703521,0.846216896504639
72,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0775005443256687,0.878998569334845
73,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.0780619167414157,0.878998569334845
74,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Down,0.0819222626354449,0.881239669615852
75,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Up,0.0824492246333244,0.881239669615852
76,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.0825359687136034,0.881239669615852
77,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0825492147936991,0.881239669615852
78,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0847248970583902,0.881732253236676
79,WP_PPAR_SIGNALING,39,Up,0.0855395439166378,0.881732253236676
80,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.086099597111136,0.881732253236676
81,WP_ALLOGRAFT_REJECTION,48,Up,0.0883318544979975,0.881732253236676
82,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0885132457476951,0.881732253236676
83,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.0890313589034599,0.881732253236676
84,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.0916407983992131,0.896770670049443
85,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.093549819911382,0.897942775705746
86,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.0948409235320479,0.897942775705746
87,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.0958992936309256,0.897942775705746
88,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.0961301268395446,0.897942775705746
89,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.0993939594546777,0.917998142379158
90,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.10288368992326,0.939671034632437
91,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.108099053532412,0.942222904673314
92,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.108142222833105,0.942222904673314
93,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.110317944303428,0.942222904673314
94,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.111769239885662,0.942222904673314
95,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.111782863831744,0.942222904673314
96,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.113103918223301,0.942222904673314
97,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.114641205539097,0.942222904673314
98,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.11867336162623,0.942222904673314
99,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.119211995108825,0.942222904673314
100,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.121742404731968,0.942222904673314
101,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.125582795351707,0.942222904673314
102,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.126356211991039,0.942222904673314
103,WP_TRANSLATION_FACTORS,49,Down,0.126665300997484,0.942222904673314
104,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.12684348321715,0.942222904673314
105,WP_NEPHROGENESIS,4,Down,0.127067681092159,0.942222904673314
106,WP_SPINAL_CORD_INJURY,63,Up,0.130424685127781,0.942222904673314
107,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.131111967553333,0.942222904673314
108,WP_SMALL_LIGAND_GPCRS,7,Up,0.134760246449331,0.942222904673314
109,WP_SPINA_BIFIDA,10,Up,0.135016863479532,0.942222904673314
110,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.137213883745448,0.942222904673314
111,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.137511313096224,0.942222904673314
112,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.138180814298206,0.942222904673314
113,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.139464709604435,0.942222904673314
114,WP_FOLATE_METABOLISM,36,Up,0.143708217462474,0.942222904673314
115,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.144982938024428,0.942222904673314
116,WP_ENERGY_METABOLISM,41,Down,0.14551096568166,0.942222904673314
117,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.147098176872494,0.942222904673314
118,WP_DRAVET_SYNDROME,12,Down,0.148446868432126,0.942222904673314
119,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.148666528852241,0.942222904673314
120,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.149188426531331,0.942222904673314
121,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.150320802737156,0.942222904673314
122,WP_FOXP3_IN_COVID19,9,Up,0.1511218449564,0.942222904673314
123,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.151514710438014,0.942222904673314
124,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.155753974853325,0.942222904673314
125,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.156040612318375,0.942222904673314
126,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.156617174168598,0.942222904673314
127,WP_HEME_BIOSYNTHESIS,8,Up,0.156617174168598,0.942222904673314
128,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.158745239632908,0.942222904673314
129,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.160177946612382,0.942222904673314
130,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.161804993643837,0.942222904673314
131,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.162046788433769,0.942222904673314
132,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.162351936913993,0.942222904673314
133,WP_VITAMIN_B12_METABOLISM,23,Up,0.162719530355048,0.942222904673314
134,WP_CORI_CYCLE,11,Up,0.16617739964466,0.942222904673314
135,WP_RETINOL_METABOLISM,6,Down,0.168955126479751,0.942222904673314
136,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.169353639531666,0.942222904673314
137,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.169657441375245,0.942222904673314
138,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Up,0.170835346723543,0.942222904673314
139,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.172434368263438,0.942222904673314
140,WP_NUCLEOTIDE_GPCRS,5,Down,0.17268045653421,0.942222904673314
141,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.173447511519098,0.942222904673314
142,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.173774245003818,0.942222904673314
143,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.175163288733212,0.942222904673314
144,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Up,0.175664899089781,0.942222904673314
145,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.176710451176435,0.942222904673314
146,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.177326949141478,0.942222904673314
147,WP_BASE_EXCISION_REPAIR,29,Up,0.178791931725659,0.942222904673314
148,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.179238824792284,0.942222904673314
149,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.180273639052796,0.942222904673314
150,WP_IRINOTECAN_PATHWAY,5,Up,0.180772276143369,0.942222904673314
151,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.180808787681783,0.942222904673314
152,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Down,0.181028563078554,0.942222904673314
153,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.1823125041663,0.942222904673314
154,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.182784365610554,0.942222904673314
155,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.18371894651569,0.942222904673314
156,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.183850958348824,0.942222904673314
157,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.185512318352486,0.942222904673314
158,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.185943588984404,0.942222904673314
159,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Down,0.186378002039008,0.942222904673314
160,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.188394432377218,0.942222904673314
161,WP_AEROBIC_GLYCOLYSIS,10,Up,0.190748692224595,0.942222904673314
162,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.190748692224595,0.942222904673314
163,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.193539745670656,0.942222904673314
164,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Down,0.193576917610768,0.942222904673314
165,WP_SERINE_METABOLISM,5,Up,0.194082420792147,0.942222904673314
166,WP_PREIMPLANTATION_EMBRYO,20,Up,0.194303361464241,0.942222904673314
167,WP_IL4_SIGNALING,50,Down,0.195089901556342,0.942222904673314
168,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.19808064795207,0.942222904673314
169,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Down,0.199326870236854,0.942222904673314
170,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.20005512041573,0.942222904673314
171,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.200084864292168,0.942222904673314
172,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.200147592119295,0.942222904673314
173,WP_BENZENE_METABOLISM,3,Up,0.20039677833051,0.942222904673314
174,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.20089505714939,0.942222904673314
175,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.200949056396083,0.942222904673314
176,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.208858005360878,0.942222904673314
177,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.208942942278849,0.942222904673314
178,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.211098269744879,0.942222904673314
179,WP_AXON_GUIDANCE,35,Up,0.213639662949767,0.942222904673314
180,WP_HUNGER_AND_SATIETY,2,Down,0.216950886609857,0.942222904673314
181,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.2175708831421,0.942222904673314
182,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.221665396603867,0.942222904673314
183,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Up,0.224505061989531,0.942222904673314
184,WP_CHOLESTASIS,9,Down,0.224916032803196,0.942222904673314
185,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.230607331598539,0.942222904673314
186,WP_G13_SIGNALING,29,Down,0.231074374664285,0.942222904673314
187,WP_OVARIAN_INFERTILITY,20,Down,0.23430654279465,0.942222904673314
188,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.23493169884344,0.942222904673314
189,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.237324713747948,0.942222904673314
190,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.238703797853365,0.942222904673314
191,WP_SEROTONIN_AND_ANXIETY,7,Down,0.242530800628156,0.942222904673314
192,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.245766364014809,0.942222904673314
193,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.246342759239287,0.942222904673314
194,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Up,0.247320731754035,0.942222904673314
195,WP_SPHINGOLIPID_PATHWAY,19,Down,0.248123923450311,0.942222904673314
196,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.248760214194307,0.942222904673314
197,WP_COMPLEMENT_ACTIVATION,11,Up,0.251859781410043,0.942222904673314
198,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.25441165185304,0.942222904673314
199,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.25511732373052,0.942222904673314
200,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.257366705864893,0.942222904673314
201,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.257520779100077,0.942222904673314
202,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.259080232455983,0.942222904673314
203,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.260445741340294,0.942222904673314
204,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.264503188336861,0.942222904673314
205,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.26470163747866,0.942222904673314
206,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.265494654902516,0.942222904673314
207,WP_IL1_SIGNALING,51,Down,0.267459324764438,0.942222904673314
208,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.268786767624592,0.942222904673314
209,WP_ATR_SIGNALING,10,Up,0.269053249071805,0.942222904673314
210,WP_NAD_METABOLISM,11,Down,0.269694181810663,0.942222904673314
211,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.269723644153194,0.942222904673314
212,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.269994330705214,0.942222904673314
213,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.270532362840099,0.942222904673314
214,WP_HEART_DEVELOPMENT,16,Up,0.271228531271683,0.942222904673314
215,WP_JOUBERT_SYNDROME,71,Down,0.272218328879526,0.942222904673314
216,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.272284411992224,0.942222904673314
217,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.273138930939053,0.942222904673314
218,WP_CIRCADIAN_RHYTHM_GENES,114,Up,0.273799565817427,0.942222904673314
219,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.275358593148081,0.942222904673314
220,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Down,0.276070727168571,0.942222904673314
221,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.276514607323949,0.942222904673314
222,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.279856477412393,0.942222904673314
223,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.280324538014763,0.942222904673314
224,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.280387807403183,0.942222904673314
225,WP_VALPROIC_ACID_PATHWAY,8,Down,0.280692505361993,0.942222904673314
226,WP_ASPIRIN_AND_MIRNAS,8,Down,0.281965419318147,0.942222904673314
227,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.282286228452928,0.942222904673314
228,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.285757563341116,0.942222904673314
229,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.286931345618674,0.942222904673314
230,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Up,0.287955861745273,0.942222904673314
231,WP_IL18_SIGNALING,186,Up,0.290525180511442,0.942222904673314
232,WP_THERMOGENESIS,72,Down,0.290942222815646,0.942222904673314
233,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.293925045198954,0.942222904673314
234,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.296256782445912,0.942222904673314
235,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.297380767426823,0.942222904673314
236,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.298344962128426,0.942222904673314
237,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.299462250321041,0.942222904673314
238,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Down,0.300403722230932,0.942222904673314
239,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.302607115184894,0.942222904673314
240,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.303820366076357,0.942222904673314
241,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.304004582744883,0.942222904673314
242,WP_CHOLESTEROL_METABOLISM,52,Down,0.304384741730013,0.942222904673314
243,WP_TAMOXIFEN_METABOLISM,2,Up,0.305010763317241,0.942222904673314
244,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.306415626980527,0.942222904673314
245,WP_WNT_SIGNALING_WP428,58,Down,0.306552355679972,0.942222904673314
246,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.308397039156213,0.942222904673314
247,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.308748043660306,0.942222904673314
248,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.309790278978966,0.942222904673314
249,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.313169437009019,0.942222904673314
250,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.316162183000905,0.942222904673314
251,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.317006290564111,0.942222904673314
252,WP_DNA_DAMAGE_RESPONSE,57,Up,0.318263163490432,0.942222904673314
253,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.321542951792211,0.942222904673314
254,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.322033802978078,0.942222904673314
255,WP_P38_MAPK_SIGNALING,31,Down,0.322157088104587,0.942222904673314
256,WP_EGFEGFR_SIGNALING,136,Up,0.322665105703387,0.942222904673314
257,WP_ADIPOGENESIS,84,Up,0.322747003607584,0.942222904673314
258,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.323368190926651,0.942222904673314
259,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.32392559698072,0.942222904673314
260,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Down,0.324490573556214,0.942222904673314
261,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.328521755647637,0.942222904673314
262,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.329349851018087,0.942222904673314
263,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.329349851018087,0.942222904673314
264,WP_PROSTAGLANDIN_SIGNALING,20,Down,0.332202480522542,0.942222904673314
265,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.332807326166481,0.942222904673314
266,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.333804935540359,0.942222904673314
267,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.335127074739628,0.942222904673314
268,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.335651592364171,0.942222904673314
269,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.335834272834786,0.942222904673314
270,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Down,0.336663608344229,0.942222904673314
271,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.33678988334533,0.942222904673314
272,WP_TRANSSULFURATION_PATHWAY,8,Down,0.336939435930835,0.942222904673314
273,WP_IL26_SIGNALING,31,Up,0.337450516808237,0.942222904673314
274,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.337656997975419,0.942222904673314
275,WP_GPCRS_OTHER,11,Up,0.339349880111132,0.942222904673314
276,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.340209075993156,0.942222904673314
277,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.340798253463101,0.942222904673314
278,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.341032757156179,0.942222904673314
279,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.341100582216847,0.942222904673314
280,WP_PRION_DISEASE_PATHWAY,28,Down,0.341295431035482,0.942222904673314
281,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.342460346667196,0.942222904673314
282,WP_OSTEOCLAST_SIGNALING,8,Up,0.34331555496346,0.942222904673314
283,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.343662474843688,0.942222904673314
284,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.344533745062215,0.942222904673314
285,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.345223445895328,0.942222904673314
286,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.345293753121225,0.942222904673314
287,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.346190305525008,0.942222904673314
288,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.346304907709963,0.942222904673314
289,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Up,0.346328344635465,0.942222904673314
290,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.347217412654864,0.942222904673314
291,WP_NEURAL_CREST_DIFFERENTIATION,37,Up,0.34735702374901,0.942222904673314
292,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.34952281236848,0.942222904673314
293,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.350327619432694,0.942222904673314
294,WP_IL7_SIGNALING,23,Up,0.350420026479602,0.942222904673314
295,WP_NEPHROTIC_SYNDROME,27,Up,0.350483283119525,0.942222904673314
296,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.354644095303625,0.942222904673314
297,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.354698133480096,0.942222904673314
298,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.360196353324911,0.942222904673314
299,WP_RETT_SYNDROME,31,Down,0.361980968788395,0.942222904673314
300,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.362422557521839,0.942222904673314
301,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.362436025647175,0.942222904673314
302,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.362880778874608,0.942222904673314
303,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.363296361517553,0.942222904673314
304,WP_IL11_SIGNALING,40,Up,0.363603704975218,0.942222904673314
305,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Up,0.363883183107619,0.942222904673314
306,WP_FOXA2_PATHWAY,9,Up,0.364971532405299,0.942222904673314
307,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.364987437145206,0.942222904673314
308,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.365515326366195,0.942222904673314
309,WP_GPR40_PATHWAY,7,Up,0.366671499765105,0.942222904673314
310,WP_NEOVASCULARIZATION_PROCESSES,20,Up,0.367486722691265,0.942222904673314
311,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.36818366166406,0.942222904673314
312,WP_TRYPTOPHAN_METABOLISM,18,Down,0.369995602918543,0.942222904673314
313,WP_IL17_SIGNALING,25,Up,0.370201423623808,0.942222904673314
314,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.3715858618516,0.942222904673314
315,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.37233568857685,0.942222904673314
316,WP_SLEEP_REGULATION,10,Up,0.373420208164412,0.942222904673314
317,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.37420895433116,0.942222904673314
318,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.374998394956722,0.942222904673314
319,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.376903715957177,0.942222904673314
320,WP_LUNG_FIBROSIS,30,Down,0.378276586869422,0.942222904673314
321,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Down,0.378470370007549,0.942222904673314
322,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.378547595956139,0.942222904673314
323,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.378981009766827,0.942222904673314
324,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.379441133527854,0.942222904673314
325,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.380038303906663,0.942222904673314
326,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.381321733616012,0.942222904673314
327,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.384533947917528,0.942222904673314
328,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.384799399335125,0.942222904673314
329,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.385807660920934,0.942222904673314
330,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.386625579578603,0.942222904673314
331,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.38678102703564,0.942222904673314
332,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.387187824074747,0.942222904673314
333,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.387619607213972,0.942222904673314
334,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.388039794488369,0.942222904673314
335,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.390081261946396,0.942222904673314
336,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.39052088246992,0.942222904673314
337,WP_RANKLRANK_SIGNALING,47,Up,0.390627784595717,0.942222904673314
338,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.391275671347248,0.942222904673314
339,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.391877732073336,0.942222904673314
340,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.391889736457932,0.942222904673314
341,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.393760339377304,0.942222904673314
342,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.394436471500465,0.942222904673314
343,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.396227120564714,0.942222904673314
344,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.396359191753711,0.942222904673314
345,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.399181319481034,0.942222904673314
346,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.39986596288751,0.942222904673314
347,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.400061234177768,0.942222904673314
348,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.402754472551338,0.942222904673314
349,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.40443054491949,0.942222904673314
350,WP_TYPE_II_DIABETES_MELLITUS,13,Up,0.404469666552397,0.942222904673314
351,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.405270902945253,0.942222904673314
352,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.405790396882852,0.942222904673314
353,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.406886482987705,0.942222904673314
354,WP_RAS_SIGNALING,113,Up,0.408373561451505,0.942222904673314
355,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.408625072865956,0.942222904673314
356,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.409882703933132,0.942222904673314
357,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.411666628875711,0.942222904673314
358,WP_CILIOPATHIES,125,Down,0.412596076800281,0.942222904673314
359,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Up,0.413649531929449,0.942222904673314
360,WP_FRAGILE_X_SYNDROME,83,Down,0.413771651076003,0.942222904673314
361,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.416446486834864,0.942222904673314
362,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.41763508148592,0.942222904673314
363,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.418115473856948,0.942222904673314
364,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.41986259518114,0.942222904673314
365,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.423151963683202,0.942222904673314
366,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.424222081816137,0.942222904673314
367,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.424991523621017,0.942222904673314
368,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.425157935894582,0.942222904673314
369,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.425629332364627,0.942222904673314
370,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.425813568481435,0.942222904673314
371,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.426073524347701,0.942222904673314
372,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.426632059326059,0.942222904673314
373,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.427553702485579,0.942222904673314
374,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.431910800511255,0.943680832221518
375,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.432284657724065,0.943680832221518
376,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.432661951004536,0.943680832221518
377,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.432807388987241,0.943680832221518
378,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.437539280727332,0.949096042988133
379,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.43998190193017,0.949096042988133
380,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.444576939793236,0.949096042988133
381,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.445079019273781,0.949096042988133
382,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.445138595533943,0.949096042988133
383,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Up,0.446980530855258,0.949096042988133
384,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.447450972643014,0.949096042988133
385,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.447562971150228,0.949096042988133
386,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.448002444510571,0.949096042988133
387,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.448030556617082,0.949096042988133
388,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.449707586472133,0.949096042988133
389,WP_VITAMIN_D_METABOLISM,6,Down,0.450874434136126,0.949096042988133
390,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.451879002117422,0.949096042988133
391,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.451911920623223,0.949096042988133
392,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.452610278407966,0.949096042988133
393,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.457785378371464,0.95112255722595
394,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,61,Down,0.460283595028031,0.95112255722595
395,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Up,0.460447082609012,0.95112255722595
396,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.460458099994698,0.95112255722595
397,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.461697369164362,0.95112255722595
398,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.461841210121409,0.95112255722595
399,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.463667338368985,0.95112255722595
400,WP_MAPK_SIGNALING,156,Up,0.464235114090346,0.95112255722595
401,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.464637617823227,0.95112255722595
402,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.46566327799233,0.95112255722595
403,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.469059642726262,0.95112255722595
404,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Up,0.47016369340681,0.95112255722595
405,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Up,0.470323480015817,0.95112255722595
406,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.472123544083251,0.95112255722595
407,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.472613259572334,0.95112255722595
408,WP_BARDETBIEDL_SYNDROME,65,Down,0.472807782045245,0.95112255722595
409,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.475755641392837,0.95112255722595
410,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.476621160694672,0.95112255722595
411,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Up,0.477146439974145,0.95112255722595
412,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.477471476454621,0.95112255722595
413,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.481612014993491,0.95112255722595
414,WP_METHYLATION_PATHWAYS,5,Up,0.481759079018763,0.95112255722595
415,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.484229765609368,0.95112255722595
416,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.48459854773081,0.95112255722595
417,WP_SILDENAFIL_TREATMENT,10,Up,0.485083693965701,0.95112255722595
418,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.48639789712355,0.95112255722595
419,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Down,0.487782679225357,0.95112255722595
420,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.488142053411588,0.95112255722595
421,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.488142053411588,0.95112255722595
422,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.492808760103422,0.95112255722595
423,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.493246521096498,0.95112255722595
424,WP_SMALL_CELL_LUNG_CANCER,67,Up,0.496107119047418,0.95112255722595
425,WP_IL3_SIGNALING,46,Down,0.496622503646279,0.95112255722595
426,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.496845238775983,0.95112255722595
427,WP_MELANOMA,52,Up,0.497284973805028,0.95112255722595
428,WP_OREXIN_RECEPTOR_PATHWAY,117,Up,0.497567996910529,0.95112255722595
429,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.497940100426239,0.95112255722595
430,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.498336663355771,0.95112255722595
431,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.498702946672001,0.95112255722595
432,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.501645497478493,0.954519904924355
433,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.502993769998247,0.954875009095979
434,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.504413573950267,0.955363958034837
435,WP_LEPTIN_SIGNALING,69,Down,0.507641709714474,0.95639044632181
436,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.50787159900076,0.95639044632181
437,WP_TNFALPHA_SIGNALING,82,Down,0.508446015866948,0.95639044632181
438,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.51187886155723,0.960649370319733
439,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.516431421184589,0.966985485680484
440,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.518333892558663,0.968341953825502
441,WP_CANCER_PATHWAYS,295,Up,0.523748765712574,0.975937870469401
442,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.524774378038291,0.975937870469401
443,WP_ERBB_SIGNALING,67,Up,0.528312031357319,0.9777734655049
444,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.528949090598439,0.9777734655049
445,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Down,0.52977834449928,0.9777734655049
446,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.532275220022373,0.9777734655049
447,WP_PROLACTIN_SIGNALING,68,Up,0.535575875803292,0.9777734655049
448,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Down,0.536205323250297,0.9777734655049
449,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.536443116674966,0.9777734655049
450,WP_ESTROGEN_SIGNALING,21,Down,0.537347321665218,0.9777734655049
451,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.538140883646982,0.9777734655049
452,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.538689540277207,0.9777734655049
453,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.539676803661782,0.9777734655049
454,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.540035466349421,0.9777734655049
455,WP_ECTODERM_DIFFERENTIATION,74,Down,0.544095990351777,0.980126659327773
456,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.54464231953041,0.980126659327773
457,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.545122689225665,0.980126659327773
458,WP_AGERAGE_PATHWAY,54,Up,0.546104635002579,0.980126659327773
459,WP_NUCLEAR_RECEPTORS,20,Up,0.550050614227067,0.980299785515088
460,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.550390756280634,0.980299785515088
461,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.553218339480796,0.980299785515088
462,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Up,0.556221580383101,0.980299785515088
463,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.559722629257745,0.980299785515088
464,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.560645087131507,0.980299785515088
465,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.561620498971545,0.980299785515088
466,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.562071478598811,0.980299785515088
467,WP_CCL18_SIGNALING,20,Up,0.563544338906304,0.980299785515088
468,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.563556022604284,0.980299785515088
469,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.565154908956302,0.980299785515088
470,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.568043437413516,0.980299785515088
471,WP_COPPER_HOMEOSTASIS,39,Up,0.568177769483685,0.980299785515088
472,WP_OPIOID_RECEPTOR_PATHWAYS,24,Up,0.568358449349948,0.980299785515088
473,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.56930812222821,0.980299785515088
474,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.57058255674236,0.980299785515088
475,WP_MEASLES_VIRUS_INFECTION,98,Down,0.57155092449348,0.980299785515088
476,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.573082083733067,0.980299785515088
477,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.573559285590873,0.980299785515088
478,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.573875296309158,0.980299785515088
479,WP_ARYLAMINE_METABOLISM,1,Up,0.574724672295419,0.980299785515088
480,WP_PYRIMIDINE_METABOLISM,71,Up,0.575901910685659,0.980299785515088
481,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.577188994234887,0.980299785515088
482,WP_WNT_SIGNALING_WP363,37,Down,0.578332967130856,0.980299785515088
483,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.580865401178417,0.980299785515088
484,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.582563346393912,0.980299785515088
485,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.585548363836938,0.980299785515088
486,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.585634260620197,0.980299785515088
487,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.585876143052469,0.980299785515088
488,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.587724747331252,0.980299785515088
489,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.589844191173382,0.980299785515088
490,WP_VITAMIN_B12_DISORDERS,9,Down,0.590579669883468,0.980299785515088
491,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.596356539238244,0.980299785515088
492,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.596687546956161,0.980299785515088
493,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.600149912097317,0.980299785515088
494,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.601263927882194,0.980299785515088
495,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.602829783759478,0.980299785515088
496,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.602865535451638,0.980299785515088
497,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.603560634595578,0.980299785515088
498,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.603629464127369,0.980299785515088
499,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Up,0.607093367205972,0.980299785515088
500,WP_BLADDER_CANCER,28,Up,0.607387400818696,0.980299785515088
501,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.608948418619375,0.980299785515088
502,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.614027613800862,0.980299785515088
503,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.61815859899535,0.980299785515088
504,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.623404852007672,0.980299785515088
505,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.62343931243927,0.980299785515088
506,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.624185658878662,0.980299785515088
507,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.625889631375038,0.980299785515088
508,WP_IL9_SIGNALING,15,Up,0.626752936979522,0.980299785515088
509,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.627104802015787,0.980299785515088
510,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.628482502750301,0.980299785515088
511,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.629324898775663,0.980299785515088
512,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.631284193364477,0.980299785515088
513,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.633568922501983,0.980299785515088
514,WP_G_PROTEIN_SIGNALING,61,Up,0.635700565349147,0.980299785515088
515,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.638019816290764,0.980299785515088
516,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Up,0.638333039525088,0.980299785515088
517,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.638421279866356,0.980299785515088
518,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.638556735914328,0.980299785515088
519,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.641478327112078,0.980299785515088
520,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.641732733076777,0.980299785515088
521,WP_OSTEOBLAST_SIGNALING,2,Up,0.641747544732312,0.980299785515088
522,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.642257891701613,0.980299785515088
523,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.646162303777557,0.980299785515088
524,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.646905667614405,0.980299785515088
525,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.647961048115576,0.980299785515088
526,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.649944220379658,0.980299785515088
527,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.654431550629351,0.980299785515088
528,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.655708197889285,0.980299785515088
529,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.65574912184214,0.980299785515088
530,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.655884223186833,0.980299785515088
531,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.656603731037166,0.980299785515088
532,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.657554262047018,0.980299785515088
533,WP_ANGIOGENESIS,12,Up,0.660370701351945,0.980299785515088
534,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.662282082443931,0.980299785515088
535,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.662835784087942,0.980299785515088
536,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.662880224499438,0.980299785515088
537,WP_MAPK_CASCADE,30,Down,0.664977369083767,0.980299785515088
538,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.666581154213101,0.980299785515088
539,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.668291986086821,0.980299785515088
540,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.669489127713072,0.980299785515088
541,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.670070742134714,0.980299785515088
542,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.673669969380934,0.980299785515088
543,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.675106109717393,0.980299785515088
544,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.675402633853424,0.980299785515088
545,WP_TGFB_SMAD_SIGNALING,7,Down,0.676299239972595,0.980299785515088
546,WP_NEUROINFLAMMATION,10,Down,0.676367810539709,0.980299785515088
547,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Up,0.678366261535056,0.980299785515088
548,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.678406933443754,0.980299785515088
549,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.678648940739331,0.980299785515088
550,WP_INSULIN_SIGNALING,129,Up,0.679516115891034,0.980299785515088
551,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.679662730013821,0.980299785515088
552,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.680236473573917,0.980299785515088
553,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.681212646128505,0.980299785515088
554,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.682126226759457,0.980299785515088
555,WP_KALLMANN_SYNDROME,11,Down,0.682220969456686,0.980299785515088
556,WP_NOTCH_SIGNALING_WP268,34,Down,0.683620753670436,0.980299785515088
557,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.684325407929965,0.980299785515088
558,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.684481296488026,0.980299785515088
559,WP_B_CELL_RECEPTOR_SIGNALING,84,Down,0.686694104975172,0.980299785515088
560,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.688427473398453,0.980299785515088
561,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.689277821707921,0.980299785515088
562,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.689348703121215,0.980299785515088
563,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.689418735095679,0.980299785515088
564,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.691304265695578,0.980299785515088
565,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.694630924094911,0.980299785515088
566,WP_ENDOTHELIN_PATHWAYS,11,Down,0.695710785279805,0.980299785515088
567,WP_NPHP1_DELETION_SYNDROME,10,Down,0.695995538719197,0.980299785515088
568,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.697964579263779,0.980299785515088
569,WP_NOTCH_SIGNALING_WP61,48,Up,0.6984416920018,0.980299785515088
570,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.699696473148352,0.980299785515088
571,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.700585799792449,0.980299785515088
572,WP_NRXN1_DELETION_SYNDROME,2,Down,0.70178046930544,0.980299785515088
573,WP_BDNFTRKB_SIGNALING,26,Up,0.701828495925883,0.980299785515088
574,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.702577110925773,0.980299785515088
575,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.703278354027117,0.980299785515088
576,WP_VEGFAVEGFR2_SIGNALING,333,Up,0.704226014397755,0.980299785515088
577,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.704321199396945,0.980299785515088
578,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.705339824952707,0.980299785515088
579,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Up,0.705679517205549,0.980299785515088
580,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.706059659760268,0.980299785515088
581,WP_MONOAMINE_TRANSPORT,11,Up,0.709886145165938,0.980299785515088
582,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.710644948219496,0.980299785515088
583,WP_EICOSANOID_SYNTHESIS,13,Down,0.714949966784013,0.980299785515088
584,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.717235111898298,0.980299785515088
585,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.717575043128697,0.980299785515088
586,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.720119622619458,0.980299785515088
587,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.722762283591784,0.980299785515088
588,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.723412584678047,0.980299785515088
589,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Up,0.723447596969331,0.980299785515088
590,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.72521936939965,0.980299785515088
591,WP_CHEMOKINE_SIGNALING,107,Up,0.726165284963031,0.980299785515088
592,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.726328269252599,0.980299785515088
593,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.727327741171093,0.980299785515088
594,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.731460562255231,0.980299785515088
595,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.732189511640785,0.980299785515088
596,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.732445471562738,0.980299785515088
597,WP_MIRNA_BIOGENESIS,6,Up,0.73248661135162,0.980299785515088
598,WP_GASTRIN_SIGNALING,92,Up,0.732674212637316,0.980299785515088
599,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.732731812696969,0.980299785515088
600,WP_BREAST_CANCER_PATHWAY,84,Down,0.733003932814075,0.980299785515088
601,WP_PEPTIDE_GPCRS,13,Up,0.733250855016512,0.980299785515088
602,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.733363016731991,0.980299785515088
603,WP_CELL_CYCLE,90,Up,0.73513680939089,0.980299785515088
604,WP_GLUCURONIDATION,7,Up,0.736350457625361,0.980299785515088
605,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.737377344138532,0.980299785515088
606,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Up,0.740205007347903,0.980299785515088
607,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.740758686605216,0.980299785515088
608,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.740769763131414,0.980299785515088
609,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.741124539296466,0.980299785515088
610,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.742844855650824,0.980299785515088
611,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.743845618275005,0.980299785515088
612,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.744203323884478,0.980299785515088
613,WP_ENDODERM_DIFFERENTIATION,80,Down,0.74572548201764,0.980299785515088
614,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.746054229865364,0.980299785515088
615,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.748368367967811,0.980299785515088
616,WP_PURINERGIC_SIGNALING,14,Up,0.750264710459331,0.980299785515088
617,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.751802877688968,0.980299785515088
618,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.752195827965615,0.980299785515088
619,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.754478953782792,0.980299785515088
620,WP_ONCOSTATIN_M_SIGNALING,55,Up,0.755482251255595,0.980299785515088
621,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.756237371609464,0.980299785515088
622,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.757109897184904,0.980299785515088
623,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.757891467636971,0.980299785515088
624,WP_PLEURAL_MESOTHELIOMA,245,Down,0.75954502945415,0.980299785515088
625,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.761359456080461,0.980299785515088
626,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.761822787356592,0.980299785515088
627,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.761923255614126,0.980299785515088
628,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.762237077639578,0.980299785515088
629,WP_HEPATITIS_B_INFECTION,116,Down,0.762316915771922,0.980299785515088
630,WP_AMINO_ACID_METABOLISM,58,Down,0.763707032633483,0.980299785515088
631,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Down,0.764963613565501,0.980299785515088
632,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.765576308956127,0.980299785515088
633,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.768254187107322,0.980299785515088
634,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.769674994568406,0.980299785515088
635,WP_CELLULAR_PROTEOSTASIS,6,Up,0.771232320155882,0.980299785515088
636,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Up,0.77149082934808,0.980299785515088
637,WP_TCELL_RECEPTOR_SIGNALING,71,Up,0.771824776077375,0.980299785515088
638,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.773126499488246,0.980299785515088
639,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.773186663930509,0.980299785515088
640,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.774640587446014,0.980299785515088
641,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.775361590915022,0.980299785515088
642,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Down,0.778890143996073,0.980299785515088
643,WP_HIPPOYAP_SIGNALING,16,Up,0.779016253857613,0.980299785515088
644,WP_ALSTROM_SYNDROME,27,Down,0.780087272995765,0.980299785515088
645,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.780618042256531,0.980299785515088
646,WP_NGLYCAN_BIOSYNTHESIS,51,Up,0.781854086879832,0.980299785515088
647,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.783118491964135,0.980299785515088
648,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.783320904471308,0.980299785515088
649,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Up,0.785218146946808,0.980299785515088
650,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.786775094304324,0.980299785515088
651,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.787059070606128,0.980299785515088
652,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.788332051071643,0.980299785515088
653,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.789068498295024,0.980299785515088
654,WP_PURINE_METABOLISM,9,Down,0.790843287549509,0.980299785515088
655,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.791757902353175,0.980299785515088
656,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.793902840281768,0.980299785515088
657,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.793950791988756,0.980299785515088
658,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.795260196150126,0.980299785515088
659,WP_STEROID_BIOSYNTHESIS,2,Up,0.796447638881778,0.980299785515088
660,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.79880058218715,0.980299785515088
661,WP_FOCAL_ADHESION,114,Down,0.800377657442869,0.980299785515088
662,WP_AUTOPHAGY,27,Down,0.802937401980561,0.980299785515088
663,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.803242857842355,0.980299785515088
664,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.804592687008812,0.980299785515088
665,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.805625211921426,0.980299785515088
666,WP_NETRINUNC5B_SIGNALING,35,Down,0.807706113023524,0.980299785515088
667,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.808574910950972,0.980299785515088
668,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.811005491685334,0.980299785515088
669,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.812104987614494,0.980299785515088
670,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.812756735552029,0.980299785515088
671,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Up,0.813113947318646,0.980299785515088
672,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.813942073723703,0.980299785515088
673,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.814431838740855,0.980299785515088
674,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.815427852134572,0.980299785515088
675,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.815811895641858,0.980299785515088
676,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.816796012099296,0.980299785515088
677,WP_PDGF_PATHWAY,35,Up,0.81709754510637,0.980299785515088
678,WP_KININKALLIKREIN_PATHWAY,2,Up,0.818342294316842,0.980299785515088
679,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Up,0.818402590247413,0.980299785515088
680,WP_MTHFR_DEFICIENCY,18,Down,0.818682704179981,0.980299785515088
681,WP_APOPTOSIS,70,Down,0.820531066864892,0.980299785515088
682,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Up,0.824535188760722,0.980299785515088
683,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.825422081783148,0.980299785515088
684,WP_DNA_REPLICATION,35,Up,0.825638716613854,0.980299785515088
685,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.826103736836767,0.980299785515088
686,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.826878119565868,0.980299785515088
687,WP_GLIOBLASTOMA_SIGNALING,66,Down,0.827244883764815,0.980299785515088
688,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.829426949503128,0.980299785515088
689,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Up,0.830289331394429,0.980299785515088
690,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.830738101651421,0.980299785515088
691,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.833295263720253,0.980299785515088
692,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.833298425846975,0.980299785515088
693,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.835180113286081,0.980299785515088
694,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.835825048358938,0.980299785515088
695,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.838074531230648,0.980299785515088
696,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.839822149735688,0.980299785515088
697,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.840760900943762,0.980299785515088
698,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.84115607136106,0.980299785515088
699,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.841381776282688,0.980299785515088
700,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.842127291513449,0.980299785515088
701,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.842127291513449,0.980299785515088
702,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.842771111891278,0.980299785515088
703,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.847505381677412,0.980299785515088
704,WP_CYTOSINE_METHYLATION,7,Down,0.847913003549694,0.980299785515088
705,WP_ALZHEIMERS_DISEASE,182,Up,0.84832915343964,0.980299785515088
706,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Up,0.84832915343964,0.980299785515088
707,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.850380395879761,0.980299785515088
708,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.85080855497952,0.980299785515088
709,WP_IL5_SIGNALING,37,Down,0.851349138718539,0.980299785515088
710,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.851803292753412,0.980299785515088
711,WP_COMPLEMENT_SYSTEM,47,Up,0.853367911946776,0.980299785515088
712,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.854080959650482,0.980299785515088
713,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Down,0.854569290261105,0.980299785515088
714,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.855116345505815,0.980299785515088
715,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.855864642014847,0.980299785515088
716,WP_BURN_WOUND_HEALING,59,Down,0.855895685110437,0.980299785515088
717,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Up,0.856495262971772,0.980299785515088
718,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.858341944032389,0.980299785515088
719,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.859624995480994,0.980299785515088
720,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.861164112172856,0.980299785515088
721,WP_IL6_SIGNALING,38,Up,0.861943004234264,0.980299785515088
722,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.862953158848297,0.980299785515088
723,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.862999687843994,0.980299785515088
724,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.863427061694554,0.980299785515088
725,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.865872028387743,0.981719734254793
726,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.869561414169779,0.984544741663304
727,WP_OSTEOPONTIN_SIGNALING,11,Down,0.872547003053279,0.986566212530667
728,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.875492615791134,0.988536992005923
729,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.877339007659924,0.988896385732361
730,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.878386533427013,0.988896385732361
731,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.880851802671972,0.988896385732361
732,WP_NRF2ARE_REGULATION,20,Up,0.881238212218626,0.988896385732361
733,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.88294431700405,0.988896385732361
734,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.88302913275858,0.988896385732361
735,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.888512621277998,0.991793172793102
736,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.889153822535827,0.991793172793102
737,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.892031387252804,0.991793172793102
738,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.892359341559481,0.991793172793102
739,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.895168475043753,0.991793172793102
740,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.896400440482978,0.991793172793102
741,WP_MATRIX_METALLOPROTEINASES,8,Up,0.896549090257144,0.991793172793102
742,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.897744990628308,0.991793172793102
743,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.897836299315756,0.991793172793102
744,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.897901167806317,0.991793172793102
745,WP_PDGFRBETA_PATHWAY,27,Up,0.90183380444172,0.991793172793102
746,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.904879225627624,0.991793172793102
747,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.906697864888287,0.991793172793102
748,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.908548849051716,0.991793172793102
749,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.910448394328361,0.991793172793102
750,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.910464662145282,0.991793172793102
751,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.911573681015972,0.991793172793102
752,WP_DNA_MISMATCH_REPAIR,21,Down,0.913257570565732,0.991793172793102
753,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Up,0.913585793594954,0.991793172793102
754,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.915759576732483,0.991793172793102
755,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.915759576732483,0.991793172793102
756,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.916065508090931,0.991793172793102
757,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.916236760885942,0.991793172793102
758,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.91854420591189,0.991793172793102
759,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.920467870883012,0.991793172793102
760,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.92078207004771,0.991793172793102
761,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.921716737556264,0.991793172793102
762,WP_IL2_SIGNALING,37,Down,0.921774043677455,0.991793172793102
763,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.922491173578881,0.991793172793102
764,WP_HYPERTROPHY_MODEL,12,Down,0.923164335529421,0.991793172793102
765,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Up,0.923434840765644,0.991793172793102
766,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.925076415497707,0.991793172793102
767,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.929006963362152,0.991793172793102
768,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.930704918607404,0.991793172793102
769,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.932307773914499,0.991793172793102
770,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.933475140496209,0.991793172793102
771,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Down,0.935041050621816,0.991793172793102
772,WP_KREBS_CYCLE_DISORDERS,11,Up,0.93512590812397,0.991793172793102
773,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.935227742715942,0.991793172793102
774,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.936789594244836,0.991793172793102
775,WP_ENDOMETRIAL_CANCER,49,Down,0.937125967530164,0.991793172793102
776,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.937633040106019,0.991793172793102
777,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.940135134224997,0.991793172793102
778,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.940206548121338,0.991793172793102
779,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.941879538543854,0.991793172793102
780,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.945835206744292,0.991793172793102
781,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.946997325506651,0.991793172793102
782,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.948109860415064,0.991793172793102
783,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.948109860415064,0.991793172793102
784,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.948359404465047,0.991793172793102
785,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.948733153768284,0.991793172793102
786,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Up,0.949050612755479,0.991793172793102
787,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.94956353648196,0.991793172793102
788,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.951236097412197,0.992279279280236
789,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Up,0.952624214196828,0.992467812509243
790,WP_ATM_SIGNALING,34,Down,0.954604331637601,0.992532458875161
791,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.955101186095197,0.992532458875161
792,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.957414577912293,0.993204204092442
793,WP_PI3KAKT_SIGNALING,173,Down,0.95816415309648,0.993204204092442
794,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.962240550124468,0.994996911619965
795,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.965053928825742,0.994996911619965
796,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.966379869695961,0.994996911619965
797,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.966445000126285,0.994996911619965
798,WP_HISTONE_MODIFICATIONS,36,Up,0.967936990610762,0.994996911619965
799,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.968311864022544,0.994996911619965
800,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.968366823961037,0.994996911619965
801,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.970935942571271,0.996391192001979
802,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.97335748117708,0.99763073507177
803,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Down,0.975202609511282,0.997895091242853
804,WP_KIT_RECEPTOR_SIGNALING,50,Up,0.979343834843332,0.997895091242853
805,WP_TAR_SYNDROME,43,Up,0.98198567283047,0.997895091242853
806,WP_CILIARY_LANDSCAPE,183,Down,0.982656646119707,0.997895091242853
807,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.983274439151819,0.997895091242853
808,WP_GLYOXYLATE_METABOLISM,5,Down,0.983458849882606,0.997895091242853
809,WP_GLUTATHIONE_METABOLISM,10,Down,0.984502483783321,0.997895091242853
810,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Down,0.986712197759358,0.997895091242853
811,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.987482370640615,0.997895091242853
812,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.987839982278254,0.997895091242853
813,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.988555604097831,0.997895091242853
814,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.988918659651451,0.997895091242853
815,WP_MRNA_PROCESSING,124,Down,0.989397201171442,0.997895091242853
816,WP_MACROPHAGE_MARKERS,8,Up,0.993053846193368,0.998914908393539
817,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.99675371252788,0.998914908393539
818,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.99749923407588,0.998914908393539
819,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.997842012023674,0.998914908393539
820,WP_IL19_SIGNALING,20,Up,0.998676416105652,0.998914908393539
821,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.998694295947317,0.998914908393539
822,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.998914908393539,0.998914908393539
